Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Ping Huang

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Renal Failure|March 10, 2016
Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patientsPo-Jen Hsiao, Po-Fan Hsieh, Chao-Hsiang Chang, et al.
Cell & Bioscience|November 18, 2022
Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axisChangcheng Guo, Yin Sun, Wei Zhai, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2022
The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)Henry H Woo, Chi-Ping Huang, William J Huang, et al.
Nature Reviews. Urology|April 18, 2023
The androgen receptor in bladder cancerJinbo Chen, Chi-Ping Huang, Chao Quan, et al.
Biochemical and Biophysical Research Communications|August 28, 2014
Anabolic androgens affect the competitive interactions in cell migration and adhesion between normal mouse urothelial cells and urothelial carcinoma cellsChi-Ping Huang, Teng-Fu Hsieh, Chi-Cheng Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2021
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signalingHao Tian, Fu-Ju Chou, Jing Tian, et al.
BMC Urology|August 7, 2019
The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting ipsilateral renal function after partial nephrectomyYu-De Wang, Chi-Ping Huang, Chao-Hsiang Chang, et al.
Cell Death and Differentiation|June 15, 2021
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signalsGang Deng, Ronghao Wang, Yin Sun, et al.
The Journal of Urology|January 29, 2016
A Mathematical Method to Calculate Tumor Contact Surface Area: An Effective Parameter to Predict Renal Function after Partial NephrectomyPo-Fan Hsieh, Yu-De Wang, Chi-Ping Huang, et al.
Scandinavian Journal of Urology|September 25, 2020
Association of acute pyelonephritis with double-J ureteral stenting: a nationwide population-based case control studySzu-Ju Chen, Chi-Ping Huang, Kun-Yuan Chiu, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Renal Failure|March 10, 2016
Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patientsPo-Jen Hsiao, Po-Fan Hsieh, Chao-Hsiang Chang, et al.
Cell & Bioscience|November 18, 2022
Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axisChangcheng Guo, Yin Sun, Wei Zhai, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2022
The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)Henry H Woo, Chi-Ping Huang, William J Huang, et al.
Nature Reviews. Urology|April 18, 2023
The androgen receptor in bladder cancerJinbo Chen, Chi-Ping Huang, Chao Quan, et al.
Biochemical and Biophysical Research Communications|August 28, 2014
Anabolic androgens affect the competitive interactions in cell migration and adhesion between normal mouse urothelial cells and urothelial carcinoma cellsChi-Ping Huang, Teng-Fu Hsieh, Chi-Cheng Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2021
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signalingHao Tian, Fu-Ju Chou, Jing Tian, et al.
BMC Urology|August 7, 2019
The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting ipsilateral renal function after partial nephrectomyYu-De Wang, Chi-Ping Huang, Chao-Hsiang Chang, et al.
Cell Death and Differentiation|June 15, 2021
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signalsGang Deng, Ronghao Wang, Yin Sun, et al.
The Journal of Urology|January 29, 2016
A Mathematical Method to Calculate Tumor Contact Surface Area: An Effective Parameter to Predict Renal Function after Partial NephrectomyPo-Fan Hsieh, Yu-De Wang, Chi-Ping Huang, et al.
Scandinavian Journal of Urology|September 25, 2020
Association of acute pyelonephritis with double-J ureteral stenting: a nationwide population-based case control studySzu-Ju Chen, Chi-Ping Huang, Kun-Yuan Chiu, et al.
Pageof 10